
PhD student @Charité Comprehensive Cancer Center Berlin
Berlin, Germany
Joined March 2022
- Tweets16
- Following45
- Followers15
- Likes26
Pinned Tweet
It’s a wrap! My final PhD paper in the @Granada_Lab just came out in @CellReports🥳 We identified circadian rhythm heterogeneity and distinct time-of-day drug sensitivity dynamics across neuroblastoma cell models⏰ Thanks to everyone who shaped this work! rb.gy/j7z0sj
Carolin Ector retweeted
⏲️Circadian rhythms meet tumour mechanobiology in this review, exploring how the breast cancer microenvironment changes across time and how this could transform chronotherapy.
🔗 Read the full text: mdpi.com/2072-6694/18/6/925
#CircadianClock #Cancer
Carolin Ector retweeted
Circadian rhythm heterogeneity modulates drug response variations in neuroblastoma models dlvr.it/TR09m3
Carolin Ector retweeted
Major work out in @NaturePhysics!
Led by @NicaGutu & Malthe Nordentoft — a multi-lab collaboration.
We show that the degree of circadian coherence between cells tunes proliferation rate 📈.
Disrupting coupling breaks clock–cell cycle coordination.
👉rdcu.be/efNaY
Carolin Ector retweeted
Our latest work is out in @CommsBio. Led by @NicaGutu & Hitoshi Ishikuma, we study how circadian rhythms shape time-of-day drug sensitivity in human cells 🕒💊. Toward time-based cancer therapy.
Supported by @medicine_e, @BMBF_Bund @ChariteBerlin
👉 rdcu.be/ee3FQ
Excited to announce that my second study with the @Granada_Lab, where we elucidated diverse circadian clock dynamics across breast cancer cells and their effect on drug sensitivity, has been published in @MolSystBiol. Thank you to the entire team! embopress.org/doi/full/10.10…
Carolin Ector retweeted
🚀 Together with @CarolinEctor, we recently published a review in Deutsches Ärzteblatt on Chronobiology in Oncology. Timing therapies for optimal effectiveness! ⏰💊
📌 Currently only in German.
🔗 aerzteblatt.de/archiv/chrono…
#Oncology #Chronobiology #MedicalResearch #CancerTreatment
Happy to share another chapter of my PhD work in the @Granada_Lab on #bioRxiv! By deep circadian phenotyping we uncovered circadian-based subtypes among breast cancer cell models and further show how circadian features shape cellular treatment responses 💊 biorxiv.org/content/10.1101/…
1
86
Carolin Ector retweeted
Thanks to @medicine_e, @BMBF_Bund, @ChariteBerlin
& @DKTK_ for the support! #CancerResearch #Chronotherapy
Carolin Ector retweeted
New Preprint from our lab, led by @CarolinEctor! We performed deep circadian phenotyping in breast cancer cell lines, uncovering circadian-based subtypes and showing the clock’s role in drug response, predicting drug sensitivity. #circadianbiology #breastcancer @BMBF_Bund
Circadian clock features define novel breast cancer subtypes and shape drug sensitivity biorxiv.org/cgi/content/shor… #biorxiv_cancer
Carolin Ector retweeted
A study in @NatureComms develops a high-throughput deep-phenotyping approach to evaluate circadian rhythms and use it to determine time-of-day drug sensitivity in cancer cell lines. go.nature.com/3Mqp80p
Carolin Ector retweeted
Grateful for the excitement around our work on the best time-of-day for drug treatments! Thanks to everyone highlighting the emerging science of chronotherapy—a field built on the pioneering work of many we admire.
News summary in 7 languages: nature.altmetric.com/details….
@SRBRHQ
Very nice article from @Inside_PM, highlighting our recent work published in @NatureComms: insideprecisionmedicine.com/…
Carolin Ector retweeted
Chemotherapy in the morning, at midday, or evening? Researchers at #CharitéBerlin have developed a method to determine the optimum time of cancer treatment. They describe their approach in the journal @NatureComms. charite.de/en/service/press_…

ALT Image of a triple-negative breast cancer cell line (MDAMB468), taken with a widefield microscope. The breast cancer cell line expresses a marker for the nucleus, which was used for real-time quantification of cells to determine the sensitivity of the cells at different times of the day © Charité | Granada Lab
Excited to share the publication of my first paper in
@NatureComms, introducing a comprehensive approach to study time-of-day effects of anti-#cancer drugs ⏰
Many thanks to the whole team, especially Adrián @Granada_Lab! Check out our work here: nature.com/articles/s41467-0…









